CA153、CEA及CA125联合检测对乳腺癌诊断的意义

目的 探讨使用CA153、CEA及CA125联合检测对乳腺癌患者的诊断价值.方法 对我院2010年5月至2011年12月收治的62例乳腺癌患者和同期健康体检的58例健康女性进行CA153、CEA及CA125联合检测,使用贝克曼DXI-800化学发光免疫分析仪,比较检测结果.结果 乳腺癌患者的CA153、CEA及CA125平均值均高于对照组患者,P＜0.05,差异有统计学意义；乳腺癌患者的CA153、CEA及CA125阳性率也明显高于健康者,P＜0.05,差异有统计学意义.结论 联合检测CA153、CEA及CA125对乳腺癌患者诊断的价值更高,值得在临床应用.

CA153, CEA and CA125 joint detection significance in the diagnosis of breast cancer

Objective To investigate the diagnostic value of CA153, CEA and CA125 detection of breast cancer patients. Methods 58 healthy women and 62 cases of breast cancer patients at the same period from May 2010 to December 2011 in our hospital were detected together with CA153, CEA and CA125 testing, using Beike Man the DXI-800 chemiluminescence immunoassay analyzer to compare test results. Results CA153, CEA and CA125 average of the breast cancer patients were higher than those of the control patients, P〈0.05, the difference was statistically significant; patients with breast cancer, CA153, CEA and CA125 positive rate were significantly higher than those of healthy subjects, P〈0.05, the difference was statistically significant.Conclusions Joint detection of CA153, CEA and CA125 in the diagnosis of breast cancer patients is worth in clinical applications.